PRMT1 in Health and Disease: Emerging Perspectives From Molecular Mechanisms to Therapeutic Strategies
MedComm · 2025-12 · 6 (12)
DOI: 10.1002/mco2.70482 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift MedComm, online erschienen am 16.11.2025. Verfasst von Yanqun Luo und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hepatology Longhua Hospital Shanghai University of Traditional Chinese Medicine Shanghai China. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 225 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
Protein arginine methyltransferase 1 (PRMT1) serves as a critical epigenetic modulator involved in a wide range of physiological and pathological processes. Previous studies have established its fundamental roles in essential cellular mechanisms such as DNA repair, transcriptional regulation, and signal transduction. Dysregulation of PRMT1 has been further associated with the pathogenesis of various diseases, including cancer, metabolic disorders, and immune dysfunction. However, a systematic synthesis of the multifaceted functions of PRMT1 across these diverse pathological contexts remains lacking. This review seeks to address this gap by comprehensively examining the molecular mechanisms, biological functions, and context‐dependent roles of PRMT1. We integrate recent advances spanning multiple disease domains, with a particular focus on cancer, chronic liver diseases, cardiovascular disorders, neurodegenerative conditions, and immune‐related pathologies. In addition, we elucidate the mechanistic links between PRMT1 dysregulation and disease pathogenesis. Further, the development and clinical potential of small‐molecule inhibitors are also summarized. This review offers new perspectives on PRMT1‐related disease mechanisms and lays a theoretical foundation for the development of targeted therapies. Ultimately, this review aims to contribute to the progression of precision medicine and the enhancement of global health outcomes.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Hepatology Longhua Hospital Shanghai University of Traditional Chinese Medicine Shanghai China.
- Institute of Interdisciplinary Integrative Medicine Research Shanghai University of Traditional Chinese Medicine Shanghai China.
ORCID-Profile: Tao Wu
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Luo, Y., Gao, Y., Deng, X., Wang, L., & Wu, T. (2025). PRMT1 in Health and Disease: Emerging Perspectives From Molecular Mechanisms to Therapeutic Strategies. MedComm, 6(12). https://doi.org/10.1002/mco2.70482
Vancouver
Luo Y, Gao Y, Deng X, Wang L, Wu T. PRMT1 in Health and Disease: Emerging Perspectives From Molecular Mechanisms to Therapeutic Strategies. MedComm. 2025;6(12). doi:10.1002/mco2.70482
BibTeX
@article{Luo2025,
author = {Luo, Yanqun and Gao, Ying and Deng, Xiaoliang and Wang, Lei and Wu, Tao},
title = {PRMT1 in Health and Disease: Emerging Perspectives From Molecular Mechanisms to Therapeutic Strategies},
journal = {MedComm},
year = {2025},
volume = {6},
number = {12},
doi = {10.1002/mco2.70482}
}
EUVIMED